Alcon EBITDA 2019-2024 | ALC

Alcon EBITDA for the quarter ending June 30, 2024 was $0.628B, a 9.98% increase year-over-year.

  • Alcon 2023 EBITDA was 2.265B, a 27.03% increase from 2022.
  • Alcon 2022 EBITDA was 1.783B, a 0.94% decline from 2021.
  • Alcon 2021 EBITDA was 1.8B, a 57.34% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Alcon EBITDA 2019-2024 | ALC

  • Alcon 2023 EBITDA was 2.265B, a 27.03% increase from 2022.
  • Alcon 2022 EBITDA was 1.783B, a 0.94% decline from 2021.
  • Alcon 2021 EBITDA was 1.8B, a 57.34% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$214.1B
Intuitive Surgical (ISRG)$183.6B
IQVIA Holdings (IQV)$40.2B
Edwards Lifesciences (EW)$39.6B
IDEXX Laboratories (IDXX)$34.7B
DexCom (DXCM)$26.8B
Waters (WAT)$23B
STERIS (STE)$22.4B
SONOVA HOLDING (SONVY)$21.9B
Hologic (HOLX)$18.7B
Fresenius Medical Care AG KGaA (FMS)$12.4B
Sysmex ADR (SSMXY)$11.9B
Globus Medical (GMED)$11.2B
Teleflex (TFX)$9.4B
Penumbra (PEN)$9B
Masimo (MASI)$8.9B
Glaukos (GKOS)$7.8B
PROCEPT BioRobotics (PRCT)$5.1B
Integer Holdings (ITGR)$4.5B
Inari Medical (NARI)$3.1B
TransMedics (TMDX)$2.9B
LivaNova (LIVN)$2.8B
Veracyte (VCYT)$2.8B
Nihon Kohden (NHNKY)$2.5B
Tandem Diabetes Care (TNDM)$2.2B
Elekta AB (EKTAY)$2.2B
Integra LifeSciences Holdings (IART)$2.1B
RxSight (RXST)$2B
Alphatec Holdings (ATEC)$1.3B
Artivion (AORT)$1.2B